Axogen Inc Stock
Axogen Inc Stock
Axogen Inc shows a slight decrease today, losing -€0.220 (-0.610%) compared to yesterday.
Pros and Cons of Axogen Inc in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Axogen Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Axogen Inc | -0.610% | 1.595% | -8.984% | 215.575% | 27.357% | 381.892% | 113.533% |
| Simulations Plus | -0.630% | 0.637% | 1.935% | -57.297% | 2.597% | -57.297% | -58.639% |
| MicroVision Inc | -2.690% | -27.116% | -14.286% | -79.224% | -70.614% | -93.554% | -98.172% |
| Fluidigm Corp. | -0.740% | -12.418% | 4.688% | -43.220% | -36.792% | -68.095% | -88.083% |
Comments
News
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam
AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
DAFNA Capital Management cut its holding in Axogen (NASDAQ:AXGN) by 265,456 shares in the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February
